Treating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case Series

Alpelisib is a α-selective phosphatidylinositol 3-kinase (PI3K) inhibitor approved for treatment of postmenopausal women, and men, with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2–), PIK3CA-mutated, advanced breast cancer (ABC). Hyperglycemia is a common,...

Descripción completa

Detalles Bibliográficos
Autores principales: Blow, Tahj, Hyde, Parker N., Falcone, John N., Neinstein, Aaron, Vasan, Neil, Chitkara, Ritika, Hurd, Maurice A., Sardesai, Sagar, Lustberg, Maryam B., Flory, James H., Volek, Jeff S., Goncalves, Marcus D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283040/
https://www.ncbi.nlm.nih.gov/pubmed/34259084
http://dx.doi.org/10.1177/15347354211032283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283040/
https://www.ncbi.nlm.nih.gov/pubmed/34259084
http://dx.doi.org/10.1177/15347354211032283

Ejemplares similares